Genmab — September 2024
-
'Genmab stock stabilized but faces uncertainties ahead' says Morgan Stanley https://za.investing.com/news/company-news/genmab-stock-stabilized-but-faces-uncertainties-ahead-says-morgan-stanley-93CH-3316303
-
Lymphoma Hub
@lymphomahub
CONGRESS | POSTER | #SOHO2024 | Daniel Kerr presents first results from the phase Ib/II EPCORE NHL-5 study investigating subcutaneous epcoritamab + pola-R-CHP as 1L treatment for #DLBCL (N=37). The ORR was 100% with CR 89%, demonstrating that epcoritamab can be combined with 1L SoC for DLBCL. https://x.com/lymphomahub/status/1831287376901013605/photo/1 -
poster on glofitamab monotherapy in pts with R/R #DLBCL https://x.com/lymphomahub/status/1831291358440464845
-
Lymphoma Hub
@lymphomahub
CONGRESS | POSTER | #SOHO2024 | Yasmin Karimi
@Yhkarimi
presents extended follow-up data beyond 2.5 years from the pivotal expansion cohort of the phase II EPCORE NHL-1 study of epcoritamab monotherapy in R/R #DLBCL (N=157). Of pts with a CR (n=65) 54% remained in CR at 30 months, with 69% PFS and 85% OS rates. https://x.com/lymphomahub/status/1831299262438641727 -
The innovaTV 301 Trial for Patients with Cervical Cancer https://www.primrmed.com/cancer-education/the-innovatv-301-trial-for-patients-with-cervical-cancer
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
